Bart A. Ploeger

Extensions to the Visual Predictive Check to facilitate model performance evaluation

Teun M. Post, Jan Freijer, Bart A. Ploeger et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2008 · 200 citations · Full text

A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus

Willem de Winter, Joost DeJongh, Teun M. Post et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 146 citations

Metabolic Syndrome, Diabetes Management, Long-term Effects +5

Explaining Variability in Tacrolimus Pharmacokinetics to Optimize Early Exposure in Adult Kidney Transplant Recipients

Rogier R. Press, Bart A. Ploeger, Jan den Hartigh et al. · Therapeutic Drug Monitoring · 2009 · 140 citations

Transplantation, Pharmacokinetic Modeling, Kidney Transplant +13

Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease

Fredrik Jeppsson, Susanna Eketjäll, Juliette Janson et al. · Journal of Biological Chemistry · 2012 · 134 citations · Full text

Mitotane has a strong and a durable inducing effect on CYP3A4 activity

Nielka P. van Erp, Henk‐Jan Guchelaar, Bart A. Ploeger et al. · European Journal of Endocrinology · 2011 · 115 citations